ANTIBODY REACTIVITY TO PHOSPHORYLCHOLINE
磷酸胆碱抗体反应性
基本信息
- 批准号:6473494
- 负责人:
- 金额:$ 14.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-07-01 至 2005-06-30
- 项目状态:已结题
- 来源:
- 关键词:Actinobacillus actinomycetemcomitans Actinomyces Bacteroides gingivalis Fusobacterium nucleatum Streptococcus sanguis affinity chromatography antibody formation antigen antibody reaction bacterial cytopathogenic effect bactericidal immunity blood chemistry clinical research cytokine dental disorder chemotherapy electron microscopy enzyme linked immunosorbent assay fluorescence microscopy genetic regulation human subject immunoglobulin G immunoglobulin M intracellular transport laboratory rabbit linkage mapping oral bacteria oral pharyngeal surgery periodontitis phosphorylcholine platelet activating factor statistics /biometry tissue /cell culture transmission electron microscopy western blottings
项目摘要
Project 5: Human antibody reactivity to phosphorylcholine: modulation of PAR-dependent biological activities, induction by phosphoryl choline- bearing plaque bacteria, and relationship to periodontal destruction. The antibody response to phosphorylcholine (PC) has been extensively studied, yet its biological significance in humans is poorly understood. It is thought that the majority of human anti-PC reflects previous exposure to S. pneumoniae, but the protective nature of this response against infection with S. pneumoniae is questionable. We have found that human anti-PC levels are significantly higher in patients who have experienced periodontal attachment loss than in healthy subjects. Furthermore, our preliminary data and recent data from other groups indicate that a number of dental plaque bacteria species, including several streptococci, actinomycetes, and strains of F. nucleatum, H. aphrophilus, and A. actinomycetemcomitans bear PC-containing antigens. Our preliminary studies also show that human anti-PC reacts with the lipid mediator platelet-activating factor (PAF). In studies in which we have sought to understand the mechanisms PC profoundly inhibits IgG2 production, as does a PAF receptor antagonist. The implication of these findings, and our fundamental hypothesis, is that anti-PC antibodies may be induced in humans by oral microorganisms in patients with periodontal attachment loss and inflammation, and that these antibodies could impact on PAF- dependent biological activities. We propose to examine the effects of human anti-PC on such functions, including IgG2 production, cytokine release, and PMN transmigration. It is also of interest that S. pneumoniae accesses the circulation by utilizing its PC antigen to mimic the PAF molecule and enter and transmigrate endothelial cells. Our preliminary data indicate that oral antigen to mimic the PAF molecule and enter and transmigrate endothelial cells. Our preliminary data indicate that oral bacteria such as S. sanguis, actinomycetes, A. actinomycetemcomitans, and F. nucleatum may also utilize this pathway. This may explain the high levels of anti-PC in periodontitis patients. Furthermore, the ability to access the circulation by this pathway could be important in promoting risk for endocarditis and cardiovascular disease. We therefore propose to further study the biological significance of the human anti-PC response as well as the possibility that oral bacterial utilize PC to enter the circulation.
项目 5:人类抗体对磷酸胆碱的反应性:PAR 依赖性生物活性的调节、携带磷酸胆碱的牙菌斑细菌的诱导以及与牙周破坏的关系。对磷酸胆碱 (PC) 的抗体反应已被广泛研究,但其在人类中的生物学意义却知之甚少。据认为,大多数人类抗 PC 反映了之前接触过肺炎链球菌,但这种针对肺炎链球菌感染的反应的保护性质值得怀疑。我们发现,牙周附着丧失患者的人类抗 PC 水平明显高于健康受试者。此外,我们的初步数据和其他小组的最新数据表明,许多牙菌斑细菌物种,包括几种链球菌、放线菌以及具核梭杆菌、嗜空杆菌和伴随放线菌菌株,都具有含 PC 的抗原。我们的初步研究还表明,人类抗 PC 与脂质介质血小板激活因子 (PAF) 发生反应。在我们试图了解 PC 深刻抑制 IgG2 产生的机制的研究中,PAF 受体拮抗剂也是如此。这些发现和我们的基本假设的含义是,牙周附着丧失和炎症患者的口腔微生物可能会在人体中诱导抗 PC 抗体,并且这些抗体可能影响 PAF 依赖性生物活性。我们建议检查人抗 PC 对这些功能的影响,包括 IgG2 产生、细胞因子释放和 PMN 迁移。同样令人感兴趣的是,肺炎链球菌通过利用其 PC 抗原模拟 PAF 分子进入循环并进入和迁移内皮细胞。我们的初步数据表明口服抗原可以模仿PAF分子并进入和迁移内皮细胞。我们的初步数据表明口腔细菌,如血链球菌、放线菌、A. actinomycetemcomitans 和 F. nucleatum 也可能利用此途径。这或许可以解释牙周炎患者体内抗 PC 水平较高的原因。此外,通过该途径进入循环的能力对于增加心内膜炎和心血管疾病的风险可能很重要。因此,我们建议进一步研究人类抗PC反应的生物学意义以及口腔细菌利用PC进入循环的可能性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HARVEY Allen SCHENKEIN其他文献
HARVEY Allen SCHENKEIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HARVEY Allen SCHENKEIN', 18)}}的其他基金
Antiphospholipids and vascular inflammation in aggressive periodontitis
侵袭性牙周炎中的抗磷脂和血管炎症
- 批准号:
8033111 - 财政年份:2008
- 资助金额:
$ 14.05万 - 项目类别:
Antiphospholipids and vascular inflammation in aggressive periodontitis
侵袭性牙周炎中的抗磷脂和血管炎症
- 批准号:
7568848 - 财政年份:2008
- 资助金额:
$ 14.05万 - 项目类别:
Antiphospholipids and vascular inflammation in aggressive periodontitis
侵袭性牙周炎中的抗磷脂和血管炎症
- 批准号:
7767678 - 财政年份:2008
- 资助金额:
$ 14.05万 - 项目类别:
Antiphospholipids and vascular inflammation in aggressive periodontitis
侵袭性牙周炎中的抗磷脂和血管炎症
- 批准号:
7370942 - 财政年份:2008
- 资助金额:
$ 14.05万 - 项目类别:
Periodontitis, Anti-phospholipids, Dendritic Cells, and Atherosclerosis
牙周炎、抗磷脂、树突状细胞和动脉粥样硬化
- 批准号:
7595038 - 财政年份:2007
- 资助金额:
$ 14.05万 - 项目类别:
GENETIC AND IMMUNOLOGIC ASPECTS OF PERIODONTAL DISEASES
牙周疾病的遗传和免疫学方面
- 批准号:
6651157 - 财政年份:2000
- 资助金额:
$ 14.05万 - 项目类别:
相似国自然基金
3种黄连属濒危植物内生放线菌多样性及其抗菌消炎活性初探
- 批准号:31600018
- 批准年份:2016
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
利用海水条件引起的海洋放线菌的指纹差异寻找抗生素先导物
- 批准号:81402846
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
一株糖霉菌属放线菌抑菌活性成分及作用机理研究
- 批准号:31400121
- 批准年份:2014
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
菊三七属药用植物内生放线菌多样性及难培养物种的分离
- 批准号:31270053
- 批准年份:2012
- 资助金额:82.0 万元
- 项目类别:面上项目
贵州省病原需氧放线菌的系统分类研究及其属间快速鉴别诊断试剂盒的研发
- 批准号:31260029
- 批准年份:2012
- 资助金额:48.0 万元
- 项目类别:地区科学基金项目
相似海外基金
SALIVA PROTEINS AND BACTERIAL ADHESION TO ORAL SURFACES
唾液蛋白质和口腔表面的细菌粘附
- 批准号:
2130103 - 财政年份:1988
- 资助金额:
$ 14.05万 - 项目类别:
SALIVA PROTEINS AND BACTERIAL ADHESION TO ORAL SURFACES
唾液蛋白质和口腔表面的细菌粘附
- 批准号:
3222396 - 财政年份:1988
- 资助金额:
$ 14.05万 - 项目类别: